Lipopolysaccharide and hypoxia-induced HIF-1 activation in human gingival fibroblasts

Journal of Periodontology

Volumn 83, Issue 6, 2012, Pages 816-824

  Li, Jing Ping ^a   Li, François Y L ^b   Xu, Aimin ^b   Cheng, Bin ^c   Tsao, Sai Wah ^b   Fung, Man Lung ^b   Leung, W Keung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cell hypoxia; Chronic periodontitis; Hypoxia inducible factor 1 subunit; Lipopolysaccharides; Toll like receptor 4; Vascular endothelial growth factor A

Indexed keywords

3-(5'-HYDROXYMETHYL-2'-FURYL)-1-BENZYLINDAZOLE; ENZYME ACTIVATOR; GUANYLATE CYCLASE; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDAZOLE DERIVATIVE; LIFICIGUAT; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL HYPOXIA; CELL NUCLEUS; CULTURE TECHNIQUE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ESCHERICHIA COLI; EXON; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENETICS; GINGIVA; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; OXYGEN CONSUMPTION; PHYSIOLOGY; TIME;

ALTERNATIVE SPLICING; ANTIBODIES, NEUTRALIZING; CELL CULTURE TECHNIQUES; CELL HYPOXIA; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATORS; ESCHERICHIA COLI; EXONS; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC VARIATION; GINGIVA; GUANYLATE CYCLASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INDAZOLES; LIPOPOLYSACCHARIDES; OXYGEN CONSUMPTION; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84861792062     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2011.110458     Document Type: Article

References (42)

1. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine 2008;42:145-151.
2. Ekuni D, Tomofuji T, Yamanaka R, Tachibana K, Yamamoto T, Watanabe T. Initial apical migration of junctional epithelium in rats following application of lipopolysaccharide and proteases. J Periodontol 2005; 76:43-48.
3. Ohnishi T, Okamoto A, Kakimoto K, Bandow K, Chiba N, Matsuguchi T. Involvement of Cot/Tp12 in bone loss during periodontitis. J Dent Res 2010;89: 192-197.
4. Takashiba S, Naruishi K, Murayama Y. Perspective of cytokine regulation for periodontal treatment: Fibroblast biology. J Periodontol 2003;74:103-110.
5. Ng KT, Li JP, Ng KM, Tipoe GL, Leung WK, Fung ML. Expression of hypoxia-inducible factor-1a in human periodontal tissue. J Periodontol 2011;82:136-141.
6. Benizri E, Ginouves A, Berra E. The magic of the hypoxia-signaling cascade. Cell Mol Life Sci 2008;65: 1133-1149.
7. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004;5:343-354.
8. Peyssonaux C, Johnson RS. An unexpected role for hypoxic response: Oxygenation and inflammation. Cell Cycle 2004;3:168-171.
9. Hellwig-Bürgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann W. Review: Hypoxia-inducible factor-1 (HlF-1): A novel transcription factor in immune reactions. J Interferon Cytokine Res 2005;25:297-310.
10. Socransky S, Hafajee AD. Periodontal infections. ln: Lindhe J, Lang NP, Karring T, eds. Clinical Periodon-tology and Implant Dentistry, 5th ed. Oxford, UK: Blackwell; 2008:207-267.
11. Mahon PC, Hirota K, Semenza GL. FIH-1: A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 2001;15:2675-2686.
12. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 2002;295:858-861.
13. Dayan F, Roux D, Brahimi-Horn MC, Pouyssegur J, Mazure NM. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Cancer Res 2006;66:3688-3698.
14. 2 tension. Proc Natl AcadSci USA 1995;92:5510-5514.
15. Richard DE, Berra E, Gothié E, Roux D, Pouysségur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 1999;274:32631-32637.
16. Berra E, Richard DE, Gothie E, Pouyssegur J. HlF-1-dependent transcriptional activity is required for oxygen-mediated HlF-1alpha degradation. FEBS Lett 2001;491:85-90.
17. Darveau RP, Pham TT, Lemley K, et al. Porphyromo-nas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect Immun 2004;72: 5041-5051.
18. Poltorak A, He X, Smirnova l, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998;282:2085-2088.
19. Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hypo-responsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 1999;162:3749-3752.
20. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000;165:618-622.
21. Frede S, Stockmann C, Freitag P, Fandrey J. Bacterial lipopolysaccharide induces HlF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Bio-chem J 2006;396:517-527.
22. Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, Nizet V. Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol 2007;178:7516-7519.
23. Sumbayev VV. LPS-induced Toll-like receptor 4 signalling triggers cross-talk of apoptosis signal-regulating kinase 1 (ASK1) and HlF-1alpha protein. FEBS Lett 2008;582:319-326.
24. Tabeta K, Yamazaki K, Akashi S, et al. Toll-like receptors confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts. Infect Immun 2000;68:3731-3735.
25. Wang PL, Oido-Mori M, Fujii T, et al. Heterogeneous expression of Toll-like receptor 4 and downregulation of Toll-like receptor 4 expression on human gingival fibroblasts by Porphyromonas gingivalis lipopolysac-charide. Biochem Biophys Res Commun 2001;288: 863-867.
26. Dehne N, Brüne B. HlF-1 in the inflammatory microenvironment. Exp Cell Res 2009;315:1791-1797.
27. Liu RS, Chu LS, Yen SH, et al. Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonida-zole. Eur J Nucl Med 1996;23:1384-1387.
28. Chun YS, Yeo EJ, Choi E, et al. Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells. Biochem Pharmacol 2001;61:947-954.
29. Yeo EJ, Chun YS, Cho YS, et al. YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst 2003;95:516-525.
30. Li SH, Shin DH, Chun YS, Lee MK, Kim MS, Park JW. A novel mode of action of YC-1 in HlF inhibition: Stimulation of FlH-dependent p300 dissociation from HlF-1alpha. Mol Cancer Ther 2008;7:3729-3738.
31. Giaccia A, Siim BG, Johnson RS. HlF-1 as a target for drug development. NatRev DrugDiscov 2003;2:803-811.
32. Cramer T, Yamanishi Y, Clausen BE, et al. HlF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003;112:645-657.
33. Rius J, Guma M, Schachtrup C, et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HlF-1alpha. Nature 2008;453:807-811.
34. Carroll VA, Ashcroft M. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-l, or loss of von HippelLindau function: lmplications for targeting the HIF pathway. Cancer Res 2006;66:6264-6270.
35. Mole DR, Ratcliffe PJ. Cellular oxygen sensing in health and disease. PediatrNephrol 2008;23:681-694.
36. Lewis JS, Lee JA, Underwood JC, Harris AL, Lewis CE. Macrophage responses to hypoxia: Relevance to disease mechanisms. J Leukoc Biol 1999;66:889-900.
37. Ohashi K, Burkart V, Flohé S, Kolb H. Cutting edge: Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000; 164:558-561.
38. Asea A, Rehli M, Kabingu E, et al. Novel signal transduction pathway utilized by extracellular HSP70: Role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002;277:15028-15034.
39. Okamura Y, Watari M, Jerud ES, et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001;276:10229-10233.
40. Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002;195:99-111.
41. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002;168:5233-5239.
42. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through tolllike receptor 4. J Immunol 2001;167:2887-2894.